General properties, biosynthesis, pharmacological properties, biological activities and daily uses of luteolin
DOI:
https://doi.org/10.56782/pps.286Keywords:
Phenolic compounds, antioxidant, anticancer, luteolinAbstract
Phenolic molecules are secondary metabolites that facilitate several biological processes. Secondary metabolites are non-nutritive substances that hold significant medicinal value. Our study combined the biological activities, general features, daily usage conditions, and biosynthesis of luteolin as reported in the literature. The literature review revealed that luteolin exhibits biological activities including antioxidant, antibacterial, anticancer, and anti-inflammatory properties. It was observed that it exerts effects on illnesses including cardioprotection, cholesterol regulation, neuroprotection, autistic spectrum disorders, gastrointestinal issues, obesity, insulin sensitivity, anxiety/depression, and arthritis. In this regard, luteolin was identified as a significant molecule for pharmacological applications.
Downloads
References
1. Ahmad, Z.; Özdemir, B.; Sevindik, M.; Eraslan, E.C.; Selamoglu, Z.; Bal, C. Phenolic compound and antioxidant potential of Hebeloma sinapizans mushroom. AgroLife Sci. J. 2023, 12(2),12-17. http://dx.doi.org/10.17930/AGL202322 DOI: https://doi.org/10.17930/AGL202322
2. Özcandır, A.; Mohammed, F.S.; Sevindik, M.; Aykurt, C.; Selamoglu, Z.; Akgül, H. Phenolic composition, total antioxidant, antiradical and antimicrobial potential of endemic Glaucium Alakirensis. Sigma J. Eng. Nat. Sci. 2024, 42(1),42-48. DOI: https://doi.org/10.14744/sigma.2024.00006
3. Korkmaz, N.; Dayangaç, A.; Sevindik, M. Antioxidant, antimicrobial and antiproliferative activities of Galium aparine. J. Fac. Pharm. Ankara 2021, 45(3), 554-564. http://dx.doi.org/10.33483/jfpau.977776 DOI: https://doi.org/10.33483/jfpau.977776
4. Mohammed, F.S.; Sevindik, M.; Uysal, I.; Sevindik, E.; Akgül, H. A natural material for suppressing the effects of oxidative stress: biological activities of Alcea kurdica. Biol. Bull. 2022, 49 (Suppl 2), S59-S66. http://dx.doi.org/10.1134/S1062359022140102 DOI: https://doi.org/10.1134/S1062359022140102
5. Doğan, M.; Mohammed, F.S.; Uysal, İ.; Mencik, K.; Kına, E.; Pehlivan, M.; Sevindik, M. Total antioxidant status, antimicrobial and antiproliferative potentials of Viola odorata (Fragrant Violet). J. Fac. Pharm. Ankara 2023, 47(3), 784-791. https://doi.org/10.33483/jfpau.1161440 DOI: https://doi.org/10.33483/jfpau.1161440
6. Kalkan, M.; Aygan, A.; Çömlekçioglu, N.; Çömlekçioğlu, U. Olea europaea Yapraklarının Bazı Biyoaktif Özelliklerinin Araştırılması, Antimikrobiyal ve Enzim İnhibisyon Etkinliğinin İncelenmesi. Turkish JAF Sci. Tech. 2023, 11(3), 496-504. http://dx.doi.org/10.24925/turjaf.v11i3.496-504.5828 DOI: https://doi.org/10.24925/turjaf.v11i3.496-504.5828
7. El-Chaghaby, G.A.; Mohammed, F.S.; Rashad, S.; Uysal, I.; Koçer, O.; Lekesiz, Ö.; Doğan, M.; Şabik, A.E.; Sevindik, M. Genus Hypericum: General Properties, Chemical Contents and Biological Activities. Egypt. J. Bot. 2024, 64(1), 1-26. https://dx.doi.org/10.21608/ejbo.2023.217116.2378 DOI: https://doi.org/10.21608/ejbo.2023.217116.2378
8. Mohammed, F.S.; Sevindik, M.; Uysal, İ.; Çesko, C.; Koraqi, H. Chemical Composition, Biological Activities, Uses, Nutritional and Mineral Contents of Cumin (Cuminum cyminum). Measurement: Food 2024, 100157. https://doi.org/10.1016/j.meafoo.2024.100157 DOI: https://doi.org/10.1016/j.meafoo.2024.100157
9. Seelinger, G.; Merfort, I.; Wölfle, U.; Schempp, C.M. Anti-carcinogenic effects of the flavonoid luteolin. Molecules 2008, 13(10), 2628-2651. https://doi.org/10.3390/molecules13102628 DOI: https://doi.org/10.3390/molecules13102628
10. Gould, K.S.; Lister, C. Flavonoid functions in plants, in Flavonoids: Chemistry, biochemistry and applications. 2006, CRC Press: United States of America. p. 397-441. DOI: https://doi.org/10.1201/9781420039443.ch8
11. Owen, R.W.; Haubner, R.; Mier, W.; Giacosa, A.; Hull, W.E.; Spiegelhalder, B.; Bartsch, H. Isolation, structure elucidation and antioxidant potential of the major phenolic and flavonoid compounds in brined olive drupes. Food Chem. Toxicol. 2003, 41(5), 703-717. https://doi.org/10.1016/s0278-6915(03)00011-5 DOI: https://doi.org/10.1016/S0278-6915(03)00011-5
12. López-Lázaro, M. Distribution and biological activities of the flavonoid luteolin. Mini Rev. Med. Chem. 2009, 9(1), 31-59. https://doi.org/10.2174/138955709787001712 DOI: https://doi.org/10.2174/138955709787001712
13. Wang, Y.; Chen, S.; Yu, O. Metabolic engineering of flavonoids in plants and microorganisms. Appl. Microbiol. Biotechnol. 2011, 91(4), 949-956. https://doi.org/10.1007/s00253-011-3449-2 DOI: https://doi.org/10.1007/s00253-011-3449-2
14. Falcone Ferreyra, M.L.; Rius, S.P.; Casati, P. Flavonoids: biosynthesis, biological functions, and biotechnological applications. Front. Plant Sci. 2012, 3, 222. https://doi.org/10.3389/fpls.2012.00222 DOI: https://doi.org/10.3389/fpls.2012.00222
15. Marín, L.; Gutiérrez-Del-Río, I.; Yagüe, P.; Manteca, Á.; Villar, C.J.; Lombó, F. De Novo Biosynthesis of Apigenin, Luteolin, and Eriodictyol in the Actinomycete Streptomyces albus and Production Improvement by Feeding and Spore Conditioning. Front. Microbiol., 2017, 8, 921. https://doi.org/10.3389/fmicb.2017.00921 DOI: https://doi.org/10.3389/fmicb.2017.00921
16. Liao, P.H.; Hung, L.M.; Chen, Y.H.; Kuan, Y.H.; Zhang, F.B.; Lin, R.H.; Shih, H.C.; Tsai, S.K.; Huang, S.S. Cardioprotective effects of luteolin during ischemia-reperfusion injury in rats. Circ. J. 2011, 75(2), 443-450. https://doi.org/10.1253/circj.cj-10-0381 DOI: https://doi.org/10.1253/circj.CJ-10-0381
17. Sun, D.; Huang, J.; Zhang, Z.; Gao, H.; Li, J.; Shen, M.; Cao, F.; Wang, H. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS One 2012, 7(3), e33491. https://doi.org/10.1371/journal.pone.0033491 DOI: https://doi.org/10.1371/journal.pone.0033491
18. Wang, G.; Li, W.; Lu, X.; Bao, P.; Zhao, X. Luteolin ameliorates cardiac failure in type I diabetic cardiomyopathy. J. Diabetes Complications 2012, 26(4), 259-265. https://doi.org/10.1016/j.jdiacomp.2012.04.007 DOI: https://doi.org/10.1016/j.jdiacomp.2012.04.007
19. Xu, T.; Li, D.; Jiang, D. Targeting cell signaling and apoptotic pathways by luteolin: cardioprotective role in rat cardiomyocytes following ischemia/reperfusion. Nutrients 2012, 4(12), 2008-2019. https://doi.org/10.3390/nu4122008 DOI: https://doi.org/10.3390/nu4122008
20. Nekohashi, M.; Ogawa, M.; Ogihara, T.; Nakazawa, K.; Kato, H.; Misaka, T.; Abe, K.; Kobayashi, S. Luteolin and quercetin affect the cholesterol absorption mediated by epithelial cholesterol transporter niemann-pick c1-like 1 in caco-2 cells and rats. PLoS One 2014, 9(5), e97901. https://doi.org/10.1371/journal.pone.0097901 DOI: https://doi.org/10.1371/journal.pone.0097901
21. Luo, Y.; Shang, P.; Li, D. Luteolin: A Flavonoid that Has Multiple Cardio-Protective Effects and Its Molecular Mechanisms. Front. Pharmacol. 2017, 8, 692. https://doi.org/10.3389/fphar.2017.00692 DOI: https://doi.org/10.3389/fphar.2017.00692
22. Dirscherl, K.; Karlstetter, M.; Ebert, S.; Kraus, D.; Hlawatsch, J.; Walczak, Y.; Moehle, C.; Fuchshofer, R.; Langmann, T. Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. J. Neuroinflammation. 2010, 7, 3. https://doi.org/10.1186/1742-2094-7-3 DOI: https://doi.org/10.1186/1742-2094-7-3
23. Theoharides, T.C.; Asadi, S.; Panagiotidou, S. A case series of a luteolin formulation (NeuroProtek®) in children with autism spectrum disorders. Int. J. Immunopathol. Pharmacol. 2012, 25(2), 317-323. https://doi.org/10.1177/039463201202500201 DOI: https://doi.org/10.1177/039463201202500201
24. Sawmiller, D.; Li, S.; Shahaduzzaman, M.; Smith, A.J.; Obregon, D.; Giunta, B.; Borlongan, C.V.; Sanberg, P.R.; Tan, J. Luteolin reduces Alzheimer's disease pathologies induced by traumatic brain injury. Int. J. Mol. Sci. 2014, 15(1), 895-904. https://doi.org/10.3390/ijms15010895 DOI: https://doi.org/10.3390/ijms15010895
25. Xu, J.; Wang, H.; Ding, K.; Zhang, L.; Wang, C.; Li, T.; Wei, W.; Lu, X. Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE pathway. Free Radic. Biol. Med. 2014, 71, 186-195. https://doi.org/10.1016/j.freeradbiomed.2014.03.009 DOI: https://doi.org/10.1016/j.freeradbiomed.2014.03.009
26. Tsilioni, I.; Taliou, A.; Francis, K.; Theoharides, T.C. Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Transl. Psychiatry 2015, 5(9), e647. https://doi.org/10.1038/tp.2015.142 DOI: https://doi.org/10.1038/tp.2015.142
27. Kwon, Y. Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease. Exp. Gerontol. 2017, 95, 39-43. https://doi.org/10.1016/j.exger.2017.05.014 DOI: https://doi.org/10.1016/j.exger.2017.05.014
28. Daily, J.W.; Kang, S.; Park, S. Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis. Biofactors 2021, 47(2), 218-231. https://doi.org/10.1002/biof.1703 DOI: https://doi.org/10.1002/biof.1703
29. Chung, J.G.; Hsia, T.C.; Kuo, H.M.; Li, Y.C.; Lee, Y.M.; Lin, S.S.; Hung, C.F. Inhibitory actions of luteolin on the growth and arylamine N-acetyltransferase activity in strains of Helicobacter pylori from ulcer patients. Toxicol. In Vitro 2001, 15(3), 191-198. https://doi.org/10.1016/s0887-2333(01)00015-7 DOI: https://doi.org/10.1016/S0887-2333(01)00015-7
30. Ding, L.; Jin, D.; Chen, X. Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes. J. Nutr. Biochem. 2010, 21(10), 941-947. https://doi.org/10.1016/j.jnutbio.2009.07.009 DOI: https://doi.org/10.1016/j.jnutbio.2009.07.009
31. Liu, Y.; Fu, X.; Lan, N.; Li, S.; Zhang, J.; Wang, S.; Li, C.; Shang, Y.; Huang, T.; Zhang, L. Luteolin protects against high fat diet-induced cognitive deficits in obesity mice. Behav. Brain Res. 2014, 267, 178-188. https://doi.org/10.1016/j.bbr.2014.02.040 DOI: https://doi.org/10.1016/j.bbr.2014.02.040
32. Zhang, L.; Han, Y.J.; Zhang, X.; Wang, X.; Bao, B.; Qu, W.; Liu, J. Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages. Diabetologia 2016, 59(10), 2219-2228. https://doi.org/10.1007/s00125-016-4039-8 DOI: https://doi.org/10.1007/s00125-016-4039-8
33. Li, B.; Du, P.; Du, Y.; Zhao, D.; Cai, Y.; Yang, Q.; Guo, Z. Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats. Life Sci. 2021, 269, 119008. https://doi.org/10.1016/j.lfs.2020.119008 DOI: https://doi.org/10.1016/j.lfs.2020.119008
34. Crupi, R.; Paterniti, I.; Ahmad, A.; Campolo, M.; Esposito, E.; Cuzzocrea, S. Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression. CNS Neurol. Disord. Drug Targets 2013, 12(7), 989-1001. https://doi.org/10.2174/18715273113129990084 DOI: https://doi.org/10.2174/18715273113129990084
35. Impellizzeri, D.; Esposito, E.; Di Paola, R.; Ahmad, A.; Campolo, M.; Peli, A.; Morittu, V.M.; Britti, D.; Cuzzocrea, S. Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. Arthritis Res. Ther. 2013, 15(6), R192. https://doi.org/10.1186/ar4382 DOI: https://doi.org/10.1186/ar4382
36. Mohammed, F.S.; Korkmaz, N.; Doğan, M.; Şabik, A.E.; Sevindik, M. Some medicinal properties of Glycyrrhiza glabra (Licorice). J. Fac. Pharm. Ankara 2021, 45(3), 524-534. https://doi.org/10.33483/jfpau.979200 DOI: https://doi.org/10.33483/jfpau.979200
37. Cai, Q.; Rahn, R.O.; Zhang, R. Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals. Cancer Lett. 1997, 119(1), 99-107. https://doi.org/10.1016/s0304-3835(97)00261-9 DOI: https://doi.org/10.1016/S0304-3835(97)00261-9
38. Habtemariam, S. Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells. J. Nat. Prod. 1997, 60(8), 775-778. https://doi.org/10.1021/np960581z DOI: https://doi.org/10.1021/np960581z
39. Ko, F.N.; Chu, C.C.; Lin, C.N.; Chang, C.C.; Teng, C.M. Isoorientin-6"-O-glucoside, a water-soluble antioxidant isolated from Gentiana arisanensis. Biochim. Biophys. Acta 1998, 1389(2), 81-90. https://doi.org/10.1016/s0005-2760(97)00157-4 DOI: https://doi.org/10.1016/S0005-2760(97)00157-4
40. Cheng, I.F.; Breen, K. On the ability of four flavonoids, baicilein, luteolin, naringenin, and quercetin, to suppress the Fenton reaction of the iron-ATP complex. Biometals 2000, 13(1), 77-83. https://doi.org/10.1023/a:1009229429250 DOI: https://doi.org/10.1023/A:1009229429250
41. Sato, Y.; Suzaki, S.; Nishikawa, T.; Kihara, M.; Shibata, H.; Higuti, T. Phytochemical flavones isolated from Scutellaria barbata and antibacterial activity against methicillin-resistant Staphylococcus aureus. J. Ethnopharmacol. 2000, 72(3), 483-488. https://doi.org/10.1016/s0378-8741(00)00265-8 DOI: https://doi.org/10.1016/S0378-8741(00)00265-8
42. Xu, H.X.; Lee, S.F. Activity of plant flavonoids against antibiotic-resistant bacteria. Phytother. Res. 2001, 15(1), 39-43. https://doi.org/10.1002/1099-1573(200102)15:1%3C39::aid-ptr684%3E3.0.co;2-r DOI: https://doi.org/10.1002/1099-1573(200102)15:1<39::AID-PTR684>3.0.CO;2-R
43. Yamamoto, H.; Ogawa, T. Antimicrobial activity of perilla seed polyphenols against oral pathogenic bacteria. Biosci. Biotechnol. Biochem. 2002, 66(4), 921-924. https://doi.org/10.1271/bbb.66.921 DOI: https://doi.org/10.1271/bbb.66.921
44. Ueda, H.; Yamazaki, C.; Yamazaki, M. Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. Biol. Pharm. Bull. 2002, 25(9), 1197-1202. https://doi.org/10.1248/bpb.25.1197 DOI: https://doi.org/10.1248/bpb.25.1197
45. Lemańska, K.; van der Woude, H.; Szymusiak, H.; Boersma, M.G.; Gliszczyńska-Swigło, A.; Rietjens, I.M.; Tyrakowska, B. The effect of catechol O-methylation on radical scavenging characteristics of quercetin and luteolin--a mechanistic insight. Free Radic. Res. 2004, 38(6), 639-647. https://doi.org/10.1080/10715760410001694062 DOI: https://doi.org/10.1080/10715760410001694062
46. Qiusheng, Z.; Xiling, S.; Xubo; Meng, S.; Changhai, W. Protective effects of luteolin-7-glucoside against liver injury caused by carbon tetrachloride in rats. Pharmazie 2004, 59(4), 286-289.
47. Horváthová, K.; Chalupa, I.; Sebová, L.; Tóthová, D.; Vachálková, A. Protective effect of quercetin and luteolin in human melanoma HMB-2 cells. Mutat. Res. 2005, 565(2), 105-112. https://doi.org/10.1016/j.mrgentox.2004.08.013 DOI: https://doi.org/10.1016/j.mrgentox.2004.08.013
48. Manju, V.; Balasubramaniyan, V.; Nalini, N. Rat colonic lipid peroxidation and antioxidant status: the effects of dietary luteolin on 1,2-dimethylhydrazine challenge. Cell. Mol. Biol. Lett. 2005, 10(3), 535-551.
49. Matsuo, M.; Sasaki, N.; Saga, K.; Kaneko, T. Cytotoxicity of flavonoids toward cultured normal human cells. Biol. Pharm. Bull. 2005, 28(2), 253-259. https://doi.org/10.1248/bpb.28.253 DOI: https://doi.org/10.1248/bpb.28.253
50. Tshikalange, T.E.; Meyer, J.J.; Hussein, A.A. Antimicrobial activity, toxicity and the isolation of a bioactive compound from plants used to treat sexually transmitted diseases. J. Ethnopharmacol. 2005, 96(3), 515-519. https://doi.org/10.1016/j.jep.2004.09.057 DOI: https://doi.org/10.1016/j.jep.2004.09.057
51. Samy, R.P.; Gopalakrishnakone, P.; Ignacimuthu, S. Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Chem. Biol. Interact. 2006, 164(1-2), 1-14. https://doi.org/10.1016/j.cbi.2006.08.018 DOI: https://doi.org/10.1016/j.cbi.2006.08.018
52. Sousa, A.; Ferreira, I.C.; Calhelha, R.; Andrade, P.B.; Valentão, P.; Seabra, R.; Estevinho, L.; Bento, A.; Pereira, J.A. Phenolics and antimicrobial activity of traditional stoned table olives 'alcaparra'. Bioorg. Med. Chem. 2006, 14(24), 8533-8538. https://doi.org/10.1016/j.bmc.2006.08.027 DOI: https://doi.org/10.1016/j.bmc.2006.08.027
53. Pereira, A.P.; Ferreira, I.C.; Marcelino, F.; Valentão, P.; Andrade, P.B.; Seabra, R.; Estevinho, L.; Bento, A.; Pereira, J.A. Phenolic compounds and antimicrobial activity of olive (Olea europaea L. Cv. Cobrançosa) leaves. Molecules 2007, 12(5), 1153-1162. https://doi.org/10.3390/12051153 DOI: https://doi.org/10.3390/12051153
54. Ju, W.; Wang, X.; Shi, H.; Chen, W.; Belinsky, S.A.; Lin, Y. A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells. Mol. Pharmacol. 2007, 71(5), 1381-1388. https://doi.org/10.1124/mol.106.032185 DOI: https://doi.org/10.1124/mol.106.032185
55. Lim, J.H.; Park, H.S.; Choi, J.K.; Lee, I.S.; Choi, H.J. Isoorientin induces Nrf2 pathway-driven antioxidant response through phosphatidylinositol 3-kinase signaling. Arch. Pharm. Res. 2007, 30(12), 1590-1598. https://doi.org/10.1007/bf02977329 DOI: https://doi.org/10.1007/BF02977329
56. Lin, Y.; Shi, R.; Wang, X.; Shen, H.M. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr. Cancer Drug Targets 2008, 8(7), 634-646. DOI: https://doi.org/10.2174/156800908786241050
57. Ashokkumar, P.; Sudhandiran, G. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomed. Pharmacother. 2008, 62(9), 590-597. DOI: https://doi.org/10.1016/j.biopha.2008.06.031
58. Yang, S.F.; Yang, W.E.; Chang, H.R.; Chu, S.C.; Hsieh, Y.S. Luteolin induces apoptosis in oral squamous cancer cells. J. Dent. Res. 2008, 87(4), 401-406. https://doi.org/10.1177/154405910808700413 DOI: https://doi.org/10.1177/154405910808700413
59. Lv, P.C.; Li, H.Q.; Xue, J.Y.; Shi, L.; Zhu, H.L. Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents. Eur. J. Med. Chem. 2009, 44(2), 908-914. https://doi.org/10.1016/j.ejmech.2008.01.013 DOI: https://doi.org/10.1016/j.ejmech.2008.01.013
60. Cai, X.; Ye, T.; Liu, C.; Lu, W.; Lu, M.; Zhang, J.; Wang, M.; Cao, P. Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells. Toxicol. In Vitro 2011, 25(7), 1385-1391. https://doi.org/10.1016/j.tiv.2011.05.009 DOI: https://doi.org/10.1016/j.tiv.2011.05.009
61. Funakoshi-Tago, M.; Nakamura, K.; Tago, K.; Mashino, T.; Kasahara, T. Anti-inflammatory activity of structurally related flavonoids, Apigenin, Luteolin and Fisetin. Int. Immunopharmacol. 2011, 11(9), 1150-1159. https://doi.org/10.1016/j.intimp.2011.03.012 DOI: https://doi.org/10.1016/j.intimp.2011.03.012
62. Kim, T.H.; Jung, J.W.; Ha, B.G.; Hong, J.M.; Park, E.K.; Kim, H.J.; Kim, S.Y. The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss. J. Nutr. Biochem. 2011, 22(1), 8-15. https://doi.org/10.1016/j.jnutbio.2009.11.002 DOI: https://doi.org/10.1016/j.jnutbio.2009.11.002
63. Lee, E.J.; Oh, S.Y.; Sung, M.K. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells. Food Chem. Toxicol. 2012, 50(11), 4136-4143. https://doi.org/10.1016/j.fct.2012.08.025 DOI: https://doi.org/10.1016/j.fct.2012.08.025
64. El Omri, A.; Han, J.; Kawada, K.; Ben Abdrabbah, M.; Isoda, H. Luteolin enhances cholinergic activities in PC12 cells through ERK1/2 and PI3K/Akt pathways. Brain Res. 2012, 1437, 16-25. https://doi.org/10.1016/j.brainres.2011.12.019 DOI: https://doi.org/10.1016/j.brainres.2011.12.019
65. Puhl, A.C.; Bernardes, A.; Silveira, R.L.; Yuan, J.; Campos, J.L.; Saidemberg, D.M.; Palma, M.S.; Cvoro, A.; Ayers, S.D.; Webb, P.; Reinach, P.S.; Skaf, M.S.; Polikarpov, I. Mode of peroxisome proliferator-activated receptor γ activation by luteolin. Mol. Pharmacol. 2012, 81(6), 788-799. https://doi.org/10.1124/mol.111.076216 DOI: https://doi.org/10.1124/mol.111.076216
66. Sun, G.B.; Sun, X.; Wang, M.; Ye, J.X.; Si, J.Y.; Xu, H.B.; Meng, X.B.; Qin, M.; Sun, J.; Wang, H.W.; Sun, X.B. Oxidative stress suppression by luteolin-induced heme oxygenase-1 expression. Toxicol. Appl. Pharmacol. 2012, 265(2), 229-240. https://doi.org/10.1016/j.taap.2012.10.002 DOI: https://doi.org/10.1016/j.taap.2012.10.002
67. Yan, J.; Wang, Q.; Zheng, X.; Sun, H.; Zhou, Y.; Li, D.; Lin, Y.; Wang, X. Luteolin enhances TNF-related apoptosis-inducing ligand's anticancer activity in a lung cancer xenograft mouse model. Biochem. Biophys. Res. Commun. 2012, 417(2), 842-846. https://doi.org/10.1016/j.bbrc.2011.12.055 DOI: https://doi.org/10.1016/j.bbrc.2011.12.055
68. George, V.C.; Naveen Kumar, D.R.; Suresh, P.K.; Kumar, S.; Kumar, R.A. Comparative studies to evaluate relative in vitro potency of luteolin in inducing cell cycle arrest and apoptosis in HaCaT and A375 cells. Asian Pac. J. Cancer Prev. 2013, 14(2), 631-637. https://doi.org/10.7314/apjcp.2013.14.2.631 DOI: https://doi.org/10.7314/APJCP.2013.14.2.631
69. Park, C.M.; Song, Y.S. Luteolin and luteolin-7-O-glucoside inhibit lipopolysaccharide-induced inflammatory responses through modulation of NF-κB/AP-1/PI3K-Akt signaling cascades in RAW 264.7 cells. Nutr. Res. Pract. 2013, 7(6), 423-429. https://doi.org/10.4162/nrp.2013.7.6.423 DOI: https://doi.org/10.4162/nrp.2013.7.6.423
70. Aneknan, P.; Kukongviriyapan, V.; Prawan, A.; Kongpetch, S.; Sripa, B.; Senggunprai, L. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells. Asian Pac. J. Cancer Prev. 2014, 15(12), 5071-5076. https://doi.org/10.3892/ol.2021.12452 DOI: https://doi.org/10.7314/APJCP.2014.15.12.5071
71. Choi, J.S.; Islam, M.N.; Ali, M.Y.; Kim, Y.M.; Park, H.J.; Sohn, H.S.; Jung, H.A. The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer's disease, anti-diabetic, and anti-inflammatory activities. Arch. Pharm. Res. 2014, 37(10), 1354-1363. https://doi.org/10.1007/s12272-014-0351-3 DOI: https://doi.org/10.1007/s12272-014-0351-3
72. Hanchinalmath, J.V.; Londonkar, R. Cytotoxic and apoptosis-inducing effect of luteolin isolated from Feronia limonia on HepG2 cells. Biolife J. 2014, 2, 1287-1292.
73. Jeon, I.H.; Kim, H.S.; Kang, H.J.; Lee, H.S.; Jeong, S.I.; Kim, S.J.; Jang, S.I. Anti-inflammatory and antipruritic effects of luteolin from Perilla (P. frutescens L.) leaves. Molecules 2014, 19(6), 6941-6951. https://doi.org/10.3390/molecules19066941 DOI: https://doi.org/10.3390/molecules19066941
74. Majumdar, D.; Jung, K.H.; Zhang, H.; Nannapaneni, S.; Wang, X.; Amin, A.R.; Chen, Z.; Chen, Z.G.; Shin, D.M. Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity. Cancer Prev. Res. 2014, 7(1), 65-73. https://doi.org/10.1158/1940-6207.capr-13-0230 DOI: https://doi.org/10.1158/1940-6207.CAPR-13-0230
75. Shen, X.F.; Ren, L.B.; Teng, Y.; Zheng, S.; Yang, X.L.; Guo, X.J.; Wang, X.Y.; Sha, K.H.; Li, N.; Xu, G.Y.; Tian, H.W.; Wang, X.Y.; Liu, X.K.; Li, J.; Huang, N. Luteolin decreases the attachment, invasion and cytotoxicity of UPEC in bladder epithelial cells and inhibits UPEC biofilm formation. Food Chem. Toxicol. 2014, 72, 204-211. https://doi.org/10.3390/biomedicines11040999 DOI: https://doi.org/10.1016/j.fct.2014.07.019
76. Fan, W.; Qian, S.; Qian, P.; Li, X. Antiviral activity of luteolin against Japanese encephalitis virus. Virus Res. 2016, 220, 112-116. https://doi.org/10.1016/j.virusres.2016.04.021 DOI: https://doi.org/10.1016/j.virusres.2016.04.021
77. Kasala, E.R.; Bodduluru, L.N.; Barua, C.C.; Gogoi, R. Antioxidant and antitumor efficacy of Luteolin, a dietary flavone on benzo(a)pyrene-induced experimental lung carcinogenesis. Biomed. Pharmacother. 2016, 82, 568-577. https://doi.org/10.1016/j.biopha.2016.05.042 DOI: https://doi.org/10.1016/j.biopha.2016.05.042
78. Xiong, J.; Wang, K.; Yuan, C.; Xing, R.; Ni, J.; Hu, G.; Chen, F.; Wang, X. Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects. Int. J. Mol. Med. 2017, 39(1), 113-125. https://doi.org/10.3892/ijmm.2016.2809 DOI: https://doi.org/10.3892/ijmm.2016.2809
79. Cao, Z.; Zhang, H.; Cai, X.; Fang, W.; Chai, D.; Wen, Y.; Chen, H.; Chu, F.; Zhang, Y. Luteolin Promotes Cell Apoptosis by Inducing Autophagy in Hepatocellular Carcinoma. Cell. Physiol. Biochem. 2017, 43(5), 1803-1812. https://doi.org/10.1159/000484066 DOI: https://doi.org/10.1159/000484066
80. Al-Megrin, W.A.; Alkhuriji, A.F.; Yousef, A.O.S.; Metwally, D.M.; Habotta, O.A.; Kassab, R.B.; Abdel Moneim, A.E.; El-Khadragy, M.F. Antagonistic Efficacy of Luteolin against Lead Acetate Exposure-Associated with Hepatotoxicity is Mediated via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activities. Antioxidants 2019, 9(1), 10. https://doi.org/10.3390/antiox9010010 DOI: https://doi.org/10.3390/antiox9010010
81. Qian, W.; Liu, M.; Fu, Y.; Zhang, J.; Liu, W.; Li, J.; Li, X.; Li, Y.; Wang, T. Antimicrobial mechanism of luteolin against Staphylococcus aureus and Listeria monocytogenes and its antibiofilm properties. Microb. Pathog. 2020, 142, 104056. https://doi.org/10.1016/j.micpath.2020.104056 DOI: https://doi.org/10.1016/j.micpath.2020.104056
82. Krupodorova, T.; Sevindik, M. Antioxidant potential and some mineral contents of wild edible mushroom Ramaria stricta. AgroLife Sci. J. 2020, 9(1), 186-191.
83. Sevindik, M.; Rasul, A.; Hussain, G.; Anwar, H.; Zahoor, M.K.; Sarfraz, I.; Kamran, K.S.; Akgul, H.; Akata, I.; Selamoglu, Z. Determination of anti-oxidative, anti-microbial activity and heavy metal contents of Leucoagaricus leucothites. Pak. J. Pharm. Sci. 2018, 31(5(Supplementary)), 2163-2168.
84. Sevindik, M.; Akgul, H.; Akata, I.; Alli, H.; Selamoglu, Z. Fomitopsis pinicola in healthful dietary approach and their therapeutic potentials. Acta Aliment. 2017, 46(4), 464-469. https://doi.org/10.1556/066.2017.46.4.9 DOI: https://doi.org/10.1556/066.2017.46.4.9
85. Bal, C.; Sevindik, M.; Akgul, H.; Selamoglu, Z. Oxidative stress index and antioxidant capacity of Lepista nuda collected from Gaziantep/Turkey. Sigma J. Eng. Nat. Sci. 2019, 37(1), 1-5. DOI: https://doi.org/10.1155/2020/5620484
86. Sevindik, M.; Gürgen, A.; Khassanov, V.T.; Bal, C. Biological Activities of Ethanol Extracts of Hericium erinaceus Obtained as a Result of Optimization Analysis. Foods 2024, 13(10), 1560. https://doi.org/10.3390/foods13101560 DOI: https://doi.org/10.3390/foods13101560
87. Mohammed, F.S.; Pehlivan, M.; Sevindik, M. Antioxidant, antibacterial and antifungal activities of different extracts of Silybum marianum collected from Duhok (Iraq). Int. J. Second. Metab. 2019, 6(4), 317-322. https://doi.org/10.21448/ijsm.581500 DOI: https://doi.org/10.21448/ijsm.581500
88. Mohammed, F.S.; Günal, S.; Pehlivan, M.; Doğan, M.; Sevindik, M.; Akgül, H. Phenolic content, antioxidant and antimicrobial potential of endemic Ferulago platycarpa. Gazi Univ. J. Sci. 2020, 33(4), 670-677. https://doi.org/10.35378/gujs.707555 DOI: https://doi.org/10.35378/gujs.707555
89. Krupodorova, T.; Barshteyn, V.; Al-Maali, G.; Sevindik, M. Requirements for vegetative growth of Hohenbuehelia myxotricha and its antimycotic activity. Polish J. Nat. Sci. 2022, 37(1), 75-92 http://dx.doi.org/10.31648/pjns.7525
90. Baba, H.; Sevindik, M.; Dogan, M.; Akgül, H. Antioxidant, antimicrobial activities and heavy metal contents of some Myxomycetes. Fresen. Environ. Bull. 2020, 29(09), 7840-7846.
91. Eraslan, E.C.; Altuntas, D.; Baba, H.; Bal, C.; Akgül, H.; Akata, I.; Sevindik, M. Some biological activities and element contents of ethanol extract of wild edible mushroom Morchella esculenta. Sigma J. Eng. Nat. Sci. 2021, 39(1), 24-28.
92. Krupodorova, T.; Barshteyn, V.; Tsygankova, V.; Sevindik, M.; Blume, Y. Strain-specific features of Pleurotus ostreatus growth in vitro and some of its biological activities. BMC Biotechnol. 2024, 24(1), 9. https://doi.org/10.1186/s12896-024-00834-9 DOI: https://doi.org/10.1186/s12896-024-00834-9
93. Karaltı, İ.; Eraslan, E.C.; Sarıdoğan, B.; Akata, I.; Sevindik, M. Total Antioxidant, Antimicrobial, Antiproliferative Potentials and Element Contents of Wild Mushroom Candolleomyces candolleanus (Agaricomycetes) from Turkey. Int. J. Med. Mushrooms 2022, 24(12), 69-76. https://doi.org/10.1615/intjmedmushrooms.2022045389 DOI: https://doi.org/10.1615/IntJMedMushrooms.2022045389
94. Weng, C.J.; Yen, G.C. Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev. 2012, 31(1-2), 323-351. https://doi.org/10.1007/s10555-012-9347-y DOI: https://doi.org/10.1007/s10555-012-9347-y
95. Wang, Z.; Zeng, M.; Wang, Z.; Qin, F.; Chen, J.; He, Z. Dietary Luteolin: A Narrative Review Focusing on Its Pharmacokinetic Properties and Effects on Glycolipid Metabolism. J. Agric. Food Chem. 2021, 69(5), 1441-1454. https://doi.org/10.1021/acs.jafc.0c08085 DOI: https://doi.org/10.1021/acs.jafc.0c08085
96. Hertog, M.G.; Feskens, E.J.; Hollman, P.C.; Katan, M.B.; Kromhout, D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993, 342(8878), 1007-1011. https://doi.org/10.1016/0140-6736(93)92876-u DOI: https://doi.org/10.1016/0140-6736(93)92876-U
97. Wang, L.; Lee, I.M.; Zhang, S.M.; Blumberg, J.B.; Buring, J.E.; Sesso, H.D. Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am. J. Clin. Nutr. 2009, 89(3), 905-912. https://doi.org/10.3945/ajcn.2008.26913 DOI: https://doi.org/10.3945/ajcn.2008.26913
98. Karakaya, S.; EL, S.N. Quercetin, luteolin, apigenin and kaempferol contents of some foods. Food Chem. 1999, 66(3), 289-292. https://doi.org/10.1016/S0308-8146(99)00049-7 DOI: https://doi.org/10.1016/S0308-8146(99)00049-7
99. Chen, T.; Li, L.P.; Lu, X.Y.; Jiang, H.D.; Zeng, S. Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract. J. Agric. Food Chem. 2007, 55(2), 273-277. https://doi.org/10.1021/jf062088r DOI: https://doi.org/10.1021/jf062088r
100. Hollman, P.C.H. Absorption, bioavailability and metabolism of flavonoids. Pharm. Biol. 2004, 42(suppl.), 74-83. https://doi.org/10.3109/13880200490893492 DOI: https://doi.org/10.3109/13880200490893492
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Memet Yazar, Mustafa Sevindik, Abdullah Ozan Polat, Oğuzhan Koçer, Hilal Kuşçu Karatepe, İmran Uysal
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
